[carbonyl-^11C]GW842166

[carbonyl-^11C]GW842166 is a radiolabeled form of GW842166 used primarily as a positron emission tomography (PET) imaging agent to study the distribution and pharmacokinetics of the parent compound in humans. The parent drug, GW842166 (also known as GW842166X), is a potent and selective agonist of the cannabinoid CB2 receptor with minimal affinity for CB1 receptors. It was developed by GlaxoSmithKline for potential use in treating inflammatory pain and has demonstrated analgesic, anti-inflammatory, and neuroprotective effects in preclinical models. The radiolabeled version ([carbonyl-^11C]) allows researchers to track its biodistribution using PET imaging techniques[9][6][8].

Other names

[11C]-GW-842,166X